CT perfusion-guided versus time-guided mechanical recanalization in acute ischemic stroke patients

Clin Neurol Neurosurg. 2013 Dec;115(12):2471-5. doi: 10.1016/j.clineuro.2013.09.036. Epub 2013 Oct 12.

Abstract

Objective: Perfusion studies are increasingly used to triage acute stroke patients for endovascular recanalization therapies. We compare the safety and efficacy of CT perfusion (CTP)-guided to time-guided mechanical recanalization in acute ischemic stroke (AIS) patients.

Methods: A review was conducted on 132 patients, 94 undergoing CTP-guided and 38 undergoing time-guided (maximum 8h from symptom onset) mechanical recanalization at our institution.

Results: The rate of partial-to-complete recanalization did not differ between the CTP and the non-CTP group (78.7% vs. 81.6%, respectively, p=0.71). ICH occurred respectively in 18.1% in the CTP group versus 31.6% in the non-CTP group (p=0.06). The overall in-hospital mortality rate was significantly lower in the CTP group (15.9% vs. 36.8%, p=0.04). In multivariable analysis, CTP-guided patient selection was an independent negative predictor of in-hospital mortality (OR=3.2; p=0.01). CTP-guided patient selection, however, was not a predictor of favorable outcome (Modified Rankin Scale 0-2 or 0-3).

Conclusions: CTP-based patient selection was associated with lower ICH and mortality rates. Favorable outcomes, however, did not differ between the 2 groups. These results may suggest a possible benefit in terms of in-hospital mortality with CTP-guided triage of AIS patients for endovascular treatment.

Keywords: Acute ischemic stroke; Computed tomography perfusion; Penumbra; Selection; Timing.

MeSH terms

  • Aged
  • Brain Ischemia / therapy*
  • Carotid Stenosis / therapy
  • Data Interpretation, Statistical
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use
  • Hospital Mortality
  • Humans
  • Infarction, Middle Cerebral Artery / therapy
  • Injections, Intra-Arterial
  • Male
  • Middle Aged
  • Patient Selection
  • Perfusion
  • Stroke / therapy*
  • Thrombectomy / methods*
  • Thrombolytic Therapy / methods*
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / therapeutic use
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator